Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Imperial College London Hammersmith Hospitals NHS Trust |
---|---|
Information provided by: | Imperial College London |
ClinicalTrials.gov Identifier: | NCT00230659 |
The inherited disease hereditary haemorrhagic telangiectasia (HHT) causes bleeding from dilated fragile vessels, particularly in the nose and gut.
However, many HHT patients develop deep venous thromboses and/or pulmonary embolism, necessitating treatments with anticoagulants that further impair control of their haemorrhagic state. Our initial observations using general coagulation tests suggest that the blood of HHT patients is intrinsically hypercoagulable.
We hypothesize that the genetically-determined abnormality in the blood vessels of HHT patients leads to alteration in the concentrations or activity of one or several of the proteins which affect blood clotting leading to a hypercoagulable state.
We propose to study levels and activity of blood coagulation factors in people with hereditary haemorrhagic telangiectasia and in normal volunteers. This should define the significance and basis for our initial observations, and will have significant implications for the clinical management of HHT patients.
Study Type: | Observational |
Study Design: | Natural History, Cross-Sectional, Case Control, Prospective Study |
Official Title: | Investigation of Coagulation Parameters in Hereditary Haemorrhagic |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United Kingdom | |
Imperial College Hammersmith Campus | |
London, United Kingdom, W12 0NN |
Principal Investigator: | Claire Shovlin | Imperial College London |
Study ID Numbers: | IC/CLS6 |
Study First Received: | September 29, 2005 |
Last Updated: | September 29, 2005 |
ClinicalTrials.gov Identifier: | NCT00230659 History of Changes |
Health Authority: | United Kingdom: Research Ethics Committee |
Hemorrhagic Disorders Cardiovascular Abnormalities Hematologic Diseases Telangiectasia, Hereditary Hemorrhagic Blood Coagulation Disorders Vascular Malformations |
Telangiectasis Vascular Diseases Hereditary Hemorrhagic Telangiectasia Congenital Abnormalities Hemostatic Disorders |
Hemorrhagic Disorders Cardiovascular Abnormalities Hematologic Diseases Telangiectasia, Hereditary Hemorrhagic Vascular Malformations |
Telangiectasis Vascular Diseases Cardiovascular Diseases Congenital Abnormalities Hemostatic Disorders |